DSwiss, Inc. Stocks

$ 0.09Last Updated 24.04.2026

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

$ 17.59M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 0.09
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable price performance

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

DSwiss, Inc., a biotech-nutraceutical company, supplies health and beauty products in Malaysia, Singapore, Indonesia, Taiwan, Macau, Hong Kong, and China. Its products include DSwiss coffee for digestive health; DSwiss kiwi, which helps the body's immune system, as well as enhances skin complexion, reduces blood pressure, and prevents heart disease and stroke; DSwiss Triple SC that focuses on stem cells; DSwiss silk mask, a mask for dry, damaged, and sensitive skin; DSwiss coffee slimming scrub, a natural body scrub for removing dirt on the skin layers; DSwiss peppermint slimming gel, a cooling agent; DSwiss new age essence delivers nutrients to moisten, brighten, and revive tired looking skin; and DSwiss enlighten essence cream, a light and nourishing cream. The company also provides DSwiss BioSpec, a medical eye-wear; Genmune-Pro, a product that helps the human's immunity system through enhancing the digestive health; SkinEra, a skin solution for acne, pimples, atopic dermatitis, dry skin, and allergy rashes; SensiBath gel; SuiSu hand purifiers and sanitizers, and air sanitizers; and MasterLiv to help support liver health, MasterHeart to help maintain optimum heart health and smooth blood circulation, and WellG, which offers nutrients needed for the metabolism of sugar and energy production. In addition, it provides DSwiss quantum magnetic analyzer, an equipment that reads and analyzes body energy field to test the health status and suggest recommendations; and AI skin analyzer machine, a facial camera for facial skin image data, as well as turnkey private label manufacturing services. Further, the company offers medical consumables, including surgical gowns and gloves, 3-ply face masks, N95 masks, protective goggles, body infrared thermometers, disposable bedsheets, and stretcher covers; and DNA microarray genotyping services. DSwiss, Inc. was incorporated in 2015 and is headquartered in Kuala Lumpur, Malaysia.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is 'expensive' on EV/EBITDA.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks